These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12460415)
1. Apheresis therapy for living-donor liver transplantation: experience for apheresis use for living-donor liver transplantation at Kyoto University. Kozaki K; Kasahara M; Oike F; Ogawa K; Fujimoto Y; Ogura Y; Ueda M; Kaihara S; Fukatsu A; Tanaka K Ther Apher; 2002 Dec; 6(6):478-83. PubMed ID: 12460415 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368 [TBL] [Abstract][Full Text] [Related]
3. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience. Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700 [TBL] [Abstract][Full Text] [Related]
4. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study. Sanada Y; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Koinuma T; Koyama K; Tanaka S; Misawa K; Wada M; Nunomiya S; Yasuda Y; Kawarasaki H Ther Apher Dial; 2012 Aug; 16(4):368-75. PubMed ID: 22817126 [TBL] [Abstract][Full Text] [Related]
5. The role of apheresis therapy in living donor liver transplantation. Kozaki K; Fukatsu A; Kasahara M; Ogura Y; Egawa H; Tanaka K Ther Apher Dial; 2004 Jun; 8(3):174-9. PubMed ID: 15154866 [TBL] [Abstract][Full Text] [Related]
6. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation. Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351 [TBL] [Abstract][Full Text] [Related]
7. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Ishida H; Koyama I; Sawada T; Utsumi K; Murakami T; Sannomiya A; Tsuji K; Yoshimura N; Tojimbara T; Nakajima I; Tanabe K; Yamaguchi Y; Fuchinoue S; Takahashi K; Teraoka S; Ito K; Toma H; Agishi T Transplantation; 2000 Aug; 70(4):681-5. PubMed ID: 10972229 [TBL] [Abstract][Full Text] [Related]
8. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation. Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390 [TBL] [Abstract][Full Text] [Related]
9. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report. Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic apheresis in renal transplantation; current practices. Keith DS J Clin Apher; 2014 Aug; 29(4):206-10. PubMed ID: 24863952 [TBL] [Abstract][Full Text] [Related]
17. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea. Kim BW; Park YK; Kim YB; Wang HJ; Kim MW Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487 [TBL] [Abstract][Full Text] [Related]
18. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation. Lee EC; Kim SH; Shim JR; Park SJ Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278 [TBL] [Abstract][Full Text] [Related]
19. Antibody elimination by apheresis in living donor liver transplant recipients. Kawagishi N; Ohkohchi N; Fujimori K; Orii T; Koyamada N; Kikuchi H; Sekiguchi S; Tsukamoto S; Sato T; Satomi S Ther Apher; 2001 Dec; 5(6):449-54. PubMed ID: 11800079 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tandem hemodialysis and immunoadsorption to desensitize kidney transplant candidates. Rostaing L; Maggioni S; Hecht C; Hermelin M; Faudel E; Kamar N; Sallusto F; Doumerc N; Allal A Exp Clin Transplant; 2015 Apr; 13 Suppl 1():165-9. PubMed ID: 25894148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]